Medical sessions | WFH World Congress 2022
In these sessions from the WFH 2022 World Congress, David Lillicrap, Len Valentino, Sophie Susen, Mrinal Gounder, Rebecca Kruse-Jarres, Christine Mrakotsky, Roger Schutgens, Dan Hart, Margaret Rand, Karina Meijer Waander van Heerde, Keith Gomez, Emna Gouider, Charles Nakar, Brian R. Long, Tiago Lopes, Claire Pouplard, Radek Kaczmarek, Johnny Mahlangu, Steve Pipe, K. Rajender Reddy, Pratima […]
What are Inhibitors?
The previous edition of this resource is also available in: Japanese This patient handbook contains basic information about inhibitors, the most serious complication of hemophilia.
Inhibitors in Hemophilia: A Primer – Traditional Chinese
Also Available In: English, Spanish This is not an official WFH translation. This resource has been translated with permission by a WFH National Member Organization (NMO), and is shared here with their kind permission. Translating organizations are encouraged to have translations reviewed by local experts, the WFH is not responsible for the translation or for […]
Inhibitors – Think differently | Virtual Summit 2020
The development of inhibitory antibodies to therapeutic factor VIII (FVIII) in up to 40% of people with severe hemophilia A (HA) is the major complication in treatment/prevention of hemorrhages. The reasons some people with HA develop inhibitors while others do not, remain unclear. In this session from the WFH 2020 Virtual Summit, Sebastien Lacroix-Desmazes, Kathleen […]
The Role of the Laboratory in Diagnosis and Management of Inhibitory Antibodies in Hemophilia
In the Monday morning session entitled Inhibitors: Clinical Aspects, Jan Astermark described the different diagnostic assays laboratories can carry out to measure inhibitors.
Inhibitors in Hemophilia: A Primer
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Traditional Chinese Inhibitors are a serious complication of hemophilia caused by an immune response to clotting factor concentrates. Treatment of inhibitors is one of the biggest challenges in hemophilia care today. This primer explains our current understanding of […]
Porcine Factor VIII
In the Monday afternoon session on alternative therapies in the management of inhibitors, Rebecca Kruse-Jarres discusses the latest developments in the use of porcine factor VIII.
Mechanisms of Inhibitors
In the Monday afternoon session on innovating immune tolerance induction for hemophilia, Shannon Meeks explains the mechanisms of inhibitors.
Mechanisms of Tolerance: Immune tolerance induction
In the Monday afternoon session on alternative therapies in the management of inhibitors, David Lillicrap explores the mechanisms of tolerance that are key to immune tolerance induction.
Fibrinolytic Inhibitors in the Management of Bleeding Disorders
A description of the mechanism of action of fibrinolytic inhibitors and their use in the treatment of inherited bleeding disorders including hemophilia A and B, von Willebrand disease, and platelet disorders.
What are Inhibitors? – Japanese
Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese この患者向けハンドブックには、血友病の最も深刻な合併症であるインヒビターについての基本情報が記載されています。